
Sign up to save your podcasts
Or
Credits: 0.25 AMA PRA Category 1 Credit™
Overview: Many patients with chronic obstructive pulmonary disease (COPD) are improperly treated with inhaled corticosteroids (ICS), increasing their risk of harm. This episode explores the latest evidence on long-term ICS risks and provides practical guidance to help you align COPD care with current guidelines—improving outcomes while minimizing adverse effects like pneumonia, cataracts, type 2 diabetes mellitus, and osteoporosis.
Episode resource links:
Guest: Jillian Joseph, PA-C
Thoughts? Suggestions? Email us at [email protected]
4.5
8383 ratings
Credits: 0.25 AMA PRA Category 1 Credit™
Overview: Many patients with chronic obstructive pulmonary disease (COPD) are improperly treated with inhaled corticosteroids (ICS), increasing their risk of harm. This episode explores the latest evidence on long-term ICS risks and provides practical guidance to help you align COPD care with current guidelines—improving outcomes while minimizing adverse effects like pneumonia, cataracts, type 2 diabetes mellitus, and osteoporosis.
Episode resource links:
Guest: Jillian Joseph, PA-C
Thoughts? Suggestions? Email us at [email protected]
488 Listeners
684 Listeners
283 Listeners
277 Listeners
255 Listeners
3,310 Listeners
1,110 Listeners
716 Listeners
191 Listeners
289 Listeners
512 Listeners
250 Listeners
366 Listeners
228 Listeners
317 Listeners